Direkt zum Inhalt
Merck
  • Use of individual retention modeling for gradient optimization in hydrophilic interaction chromatography: separation of nucleobases and nucleosides.

Use of individual retention modeling for gradient optimization in hydrophilic interaction chromatography: separation of nucleobases and nucleosides.

Journal of chromatography. A (2014-12-03)
Eva Tyteca, Davy Guillarme, Gert Desmet
ZUSAMMENFASSUNG

In this study, the separation of twelve nucleobases and nucleosides was optimized via chromatogram simulation (i.e., prediction of individual retention times and estimation of the peak widths) with the use of an empirical (reversed-phase) non-linear model proposed by Neue and Kuss. Retention time prediction errors of less than 2% were observed for all compounds on different stationary phases. As a single HILIC column could not resolve all peaks, the modeling was extended to coupled-column systems (with different stationary phase chemistries) to increase the separation efficiency and selectivity. The analytical expressions for the gradient retention factor on a coupled column system were derived and accurate retention time predictions were obtained (<2% prediction errors in general). The optimized gradient (predicted by the optimization software) included coupling of an amide and an pentahydroxy functionalized silica stationary phases with a gradient profile from 95 to 85%ACN in 6 min and resulted in almost baseline separation of the twelve nucleobases and nucleosides in less than 7 min. The final separation was obtained in less than 4h of instrument time (including equilibration times) and was fully obtained via computer-based optimization. As such, this study provides an example of a case where individual retention modeling can be used as a way to optimize the gradient conditions in the HILIC mode using a non-linear model such as the Neue and Kuss model.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Uracil, ≥99.0%
Sigma-Aldrich
Adenin, ≥99%
Sigma-Aldrich
Uridin, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Uridin, ≥99%
Sigma-Aldrich
Hypoxanthin, ≥99.0%
Sigma-Aldrich
Inosin, ≥99% (HPLC)
Sigma-Aldrich
Guanin, 98%
Sigma-Aldrich
Hypoxanthin, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Guanosin, ≥98%
Sigma-Aldrich
Adenin, BioReagent, suitable for cell culture
Sigma-Aldrich
Cytosin, ≥99%
Sigma-Aldrich
Thymin, ≥99%
Sigma-Aldrich
Cytidin, 99%
Supelco
Uracil, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Uracil, BioReagent, suitable for cell culture
Sigma-Aldrich
Cytidin, BioReagent, suitable for cell culture, powder, ≥99%
Sigma-Aldrich
Guanosin, BioReagent, suitable for cell culture
Supelco
Guanin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Uridin, BioUltra, ≥99%
Sigma-Aldrich
Guanin, BioUltra
Sigma-Aldrich
Thymin, BioReagent, suitable for cell culture
Supelco
Cytosin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Adenin, BioReagent, suitable for plant cell culture, ≥99%
Supelco
Adenin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Guanosin, ≥97.0% (HPLC)
Supelco
Thymin (Zidovudin-verwandte Verbindung C), Pharmaceutical Secondary Standard; Certified Reference Material
Adenin, European Pharmacopoeia (EP) Reference Standard
Gemcitabin Unreinheit A, European Pharmacopoeia (EP) Reference Standard
Fluorouracil Unreinheit C, European Pharmacopoeia (EP) Reference Standard
Didanosin Unreinheit A,, European Pharmacopoeia (EP) Reference Standard